Poland· PL-100377049
Agnis
A vildagliptin product containing vildagliptinum, registered in Poland by Belupo lijekovi i kozmetika d.d.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Vildagliptin is registered in 16 of 19 countries.
Countries holding a registration under ATC A10BH02 (vildagliptin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Vildagliptin · ATC A10BH02
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of vildagliptin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.32 in France to $1.98 in Switzerland — a ×6.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vildagliptin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.98
- IT Italy$1.0
- FR France$0.32
The record
At a glance
URPL (Poland)- Active substance
- Vildagliptinum
- Manufacturer
- Belupo lijekovi i kozmetika d.d.
- Country
- Poland (PL)
- ATC code
- A10BH02
- ATC class
- Vildagliptin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991350567
- gtin05909991350574
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vildagliptin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALIKVALEgis Pharmaceuticals PLC, Budapešť
- SpainGALVUS 50 mg COMPRIMIDOSNovartis Europharm Limited
- United KingdomGalvus 50mg tabletsMawdsley-Brooks & Company Ltd
- FranceGALVUS 50 mg, compriméNOVARTIS EUROPHARM (IRLANDE)
- ItalyGALVUSNOVARTIS EUROPHARM LTD
- SwedenDalmevin 50 mg TablettMedochemie Ltd
- NetherlandsGalvus 50 mg tabletten, tablettenNovartis Europharm Limited
- FinlandGalvusNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Melkart, Saxotin
- Belgium · Vildagliptin Krka
- Bulgaria · Глипвило, Далмевин
- Cyprus · Aglimon, Dalmevin
- Czechia · Alikval, Anvildis
- Germany · Vildabetes, Vildagliptin Al
- Denmark · Vildagliptin "a. E. Tiefenbacher", Vildagliptin "axunio"
- Estonia · Dalmevin, Glypvilo
- Spain · Vildagliptina, Vildagliptina Alter
- Finland · Vildagliptin Krka, Vildagliptin Ratiopharm
- France · Vildagliptine Accord, Vildagliptine Arrow
- United Kingdom (Northern Ireland) · Vildagliptin, Vildagliptin Accord-Uk
- Greece · Dalmevin, Varbos
- Croatia · Agnis, Dalmevin
- Hungary · Agartha, Alikval
- Ireland · Vildagliptin Krka
- Iceland · Galvus, Jalra
- Italy · Vildagliptin Accord, Vildagliptin Aurobindo
- Liechtenstein · Galvus, Jalra
- Lithuania · Dalmevin, Glypvilo
- Latvia · Dalmevin, Glypvilo
- Malta · Alikval, Dalmevin
- Netherlands · Vilanov, Vildagliptine Accord
- Norway · Galvus, Jalra
- Portugal · Tutecvi, Vezagla
- Romania · Agartha, Dalmevin
- Sweden · Dalmevin, Kwikaton
- Slovenia · Glypvilo
- Slovakia · Anvildis, Dalmevin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f6750a06-5dda-4312-b6c0-8e0fa9842481 GET /v1/drugs/f6750a06-5dda-4312-b6c0-8e0fa9842481?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "50 mg",
"packaging": "05909991350567 ¦ Rp ¦ 125050\n28 tabl.\n05909991350574 ¦ Rp ¦ 125051\n56 tabl.",
"substance": "Vildagliptinum 50 mg",
"common_name": "Vildagliptinum",
"pl_product_id": "100377049",
"pozwolenie_nr": "24370",
"auth_procedure": "DCP",
"authorisation_validity": "2024-07-19"
}See everything about vildagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.